BIN1 and non-small cell lung carcinoma: Wang J et al. found that the appearance of the abnormal splicing variant BIN1+12A can counteract the invasion inhibition activity and pro-apoptotic characteristics of BIN1 in non-small-cell lung cancer (NSCLC) [21].